May 20, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other eye diseases, but important nuances remain to be investigated, according to a review published in BMC Ophthalmology.“Although GLP-1 RAs have revolutionized metabolic disease management, their potential therapeutic role in ocular diseases — particularly those
May 20, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

Godot, il progetto che indaga gli effetti sugli occhi dei farmaci anti-obesità

Oral GLP-1s without fasting or reduced efficacy: Delivery approach protects peptide-based drugs from stomach acid

STEFAN SWANEPOEL | GLP-1 adoption may boost longevity, alter SA economy

GLP-1 drugs may result in better outcomes for cancer patients, study claims

GLP-1s vs Bariatric Surgery; Obesity Trends Reversing; Creatine for Menopause?

Weight loss drugs linked to surprising benefits for migraines and asthma

The Oral GLP-1 Tracker: Wegovy pill total scripts down for first time